Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.
Impaired social cognition in multiple sclerosis.
[Good practice in prophylactic care: prophylactic care and professional activation of employees with multiple sclerosis].
An observational study of venoplasty in patients with multiple sclerosis.
Natalizumab and multiple sclerosis.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
Biomechanical analysis of spasticity treatment in patients with multiple sclerosis.
A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.
Literature Commentary.
The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), Lysin motif (LysM), Domain catalytic (TLDc) domain is neuroprotective against oxidative stress.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.
Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Oncostatin M protects against demyelination by inducing a protective microglial phenotype.
HLA associations in South Asian multiple sclerosis.
The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis.

Pages